NYSE:HAEMedical Equipment
Haemonetics (HAE) Stock Extends Run As Cash Flow Strength Meets Margin Pressure
Haemonetics stock came into this quarter on a tear, with shares up almost 60% over the past three months and another 3.3% added today. That kind of move sets a high bar. The headline from the print is straightforward: revenue reached US$339.4m and adjusted earnings per share landed at US$1.14, while management pushed full year revenue guidance higher.
For a company long viewed as a steady blood and plasma technology compounder, the real story this quarter is not a growth scare. Instead, it is...